IMPLEMENTATION OF THE SCREENING MODEL FOR THE LEVEL OF DEPRESSION IN THE TREATMENT OF HIV-POSITIVE PATIENTS OF THE "TEST AND TREAT" CLINIC IN UKRAINE
DOI:
https://doi.org/10.24144/2077-6594.4.1.2022.277021Keywords:
HIV, depression, age, gender, Ukraine, screening modelAbstract
The purpose of scientific research. To investigate the prevalence of mental health disorders in HIV-infected patients as part of the implementation of the depression screening model and the provision of treatment services among HIV-positive patients of the "Test and Treat" clinic. Materials and methods. The primary material was the results of examination of 776 HIV-positive patients in the T&T clinic. The commonly accepted Patient Health Questionnaire PHQ-2 and PHQ-9 were used. Data entry and statistical analysis were performed using IBM Statistical Package for the Social Science (IBM SPSS) version 25.0. Results. Research data showed that depression occurs more often in women than in men, at the same time, according to age characteristics, both in men and in women, the highest level of depression among the patients we examined fell at the age of 35-50 years. Conclusions. It was established that depression was more often diagnosed in patients with a determining level of HIV viral load of more than 40 copies/ml, but it did not depend on the level of T4 cells at the time of examination.
References
Parcesepe A et al. Screening and treatment of common mental disorders at HIV clinics within the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. 24th International AIDS Conference, Montreal, abstract OAE0502, 2022.
Pence B. W., Miller W. C., Whetten K, Eron J. J., Gaynes B. N. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298-306
Bing E. G., Burnam M. A., Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8): 721-728.
Ciesla J. A., Roberts J. E. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158(5): 725-730.
Orlando M., Burnam M. A., Beckman R, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002; 11(2): 75-82.
Schumacher J. E., McCullumsmith C, Mugavero M. J., et al. Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS Behav. 2013; 17 (8): 2781-2791.
Tegger M. K., Crane H. M., Tapia K. A., Uldall K. K., Holte S. E., Kitahata M. M. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008; 22 (3): 233-243.
O’Cleirigh C, Magidson J. F., Skeer M. R., Mayer K. H., Safren S. A. Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary care. Psychosomatics. 2015; 56(5): 470-478.
Pence B. W., Miller W. C., Gaynes B. N., Eron J. J. Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007; 44(2): 159-166.
DiMatteo M. R., Lepper H. S., Croghan T. W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14): 2101-2107.
Zuniga J. A., Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D. The role of depression in retention in care for persons living with HIV. AIDS Patient Care STDS. 2016; 30(1): 34-38.
Mugavero M. J., Pence B. W., Whetten K., et al. Predictors of AIDS-related morbidity and mortality in a southern US cohort. AIDS Patient Care STDS. 2007; 21(9): 681-690.
Ironson G, O’Cleirigh C, Fletcher M. A., et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005; 67(6): 1013-1021.
Todd J. V., Cole S. R., Pence B. W., et al. Effects of antiretroviral therapy and depressive symptoms on all-cause mortality among HIV-infected women. Am J Epidemiol. 2017; 185(10): 869-878.
Ickovics J. R., Hamburger M. E., Vlahov D, et al; HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001; 285(11): 1466-1474.
Executive Board, 124. (2009). HIV/AIDS and mental health: report by the Secretariat. World Health Organization. http://www.who.int/iris/handle/10665/2107.
Hospytalʹnaya Shkala Trevohy y Depressyy (HADS) https://www.pfizerprofi.ru/sites/default/files/hads2106.pdf.
Shkala MADRS. URL: http://www.psychiatry.ru/stat/81.
Shkala Hamylʹtona (HDRS) dlya otsinky depresiyi. URL: https://www.pfizerprofi.ru/sites/default/files/ shkala_depressii_gamiltona.pdf.
http://uprcmsch91.prospectinfo.ru/files/zungtest.pdf.
Lopatina YA. , Zhakovych A.-M. , Kalandiya H., Naduta-Skrynnyk O. Diahnostyka depresiyi yak vazhlyva chastyna kompleksnoyi lyudyno-oriyentovanoyi dopomohy VIL-infikovanym patsiyentam v Ukrayini. Nevrolohiya, Psykhiatriya, Psykhoterapiya № 3 (54) 2020 r. Nevro_3_2020 (health-ua.com).
Spirina I. D., Hnenn O. M. Analiz rivnya depresiyi ta tryvozhnosti u VIL infikovanykh v zalezhnosti vid nayavnosti deviantnoyi povedinky. Skhidnoyevropeysʹkyy zhurnal vnutrishnʹoyi ta simeynoyi medytsyny, 2019, № 2. 289260925.pdf (core.ac.uk).
Patient Health Questionnaire-2 (PHQ-2) – Mental Disorders Screening – National HIV Curriculum (uw.edu).
Postnov O. V., Herasymenko T. V., Pozdnyakov S. V., Servetsʹkyy S. K., Pozhoha YU. V. Osoblyvosti zakhvoryuvanosti na VIL-infektsiyu u riznykh vikovykh hrupakh naselennya Odesʹkoyi oblasti. Vseukrayinsʹkyy naukovo-praktychnyy medychnyy zhurnal. «Infektsiyni khvoroby». 1 (67). – 2012. – S. 52-59.
Hémar V., Hessamfar M., Neau D. et al. A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population. Sci Rep 12, 6364 (2022). URL: https://doi.org/10.1038/s41598-022-10263-3.
Choi SKY, Boyle E, Cairney J, Collins EJ, Gardner S, Bacon J, et al. Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV Treatment Network Cohort Study. PLoS ONE 11(11). – 2016. – URL: https://doi.org/10.1371/journal.pone.0165816.
Stephanie M. Matt, Peter J. Gaskill. Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults. Brain Res. – 2019. – Nov 15; 1723: 146398. DOI: 10.1016/j.brainres.2019.146398.
